Prostate cancer patients with metastatic disease and low-volume primary tumors appear to have a poor prognosis, according to ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

The latest edition of an annual report finds new cases continue to rise and outcomes have worsened for some cancers.

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...

THOUSANDS more men will get a life-saving prostate cancer drug on the NHS in a win for The Sun after we revealed the deadly ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Cartoonist Scott Adams died at 68 after a prolonged battle with prostate cancer. To know what its symptoms, causes, ...

Using de-identified data from the National Cancer Institute, researchers followed 205 patients—average age, 61 years—with prostate cancer and preexisting depression. Patients with both conditions had ...

Charity hails ‘momentous’ decision to give abiraterone to about 8,000 newly diagnosed men each year ...